A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults.
A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults.
Recruiting · NCT07366866 · Registry updated 2026-03-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults. | autoimmune disease, immune system disorder | Recruiting | Phase 1 | 2026-03-25 | NCT07366866 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Changchun GeneScience Pharmaceutical Co., Ltd. | 50 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Huashan Hospital | Shanghai | China | 15 |